Cart
sales@molnova.com
Levolansoprazole
CAS No. 138530-95-7
Levolansoprazole( (S)-Lansoprazole | (-)-Lansoprazole )
Catalog No. M23544 CAS No. 138530-95-7
Levolansoprazole, a proton pump inhibitor, irreversibly inhibits H+/K+-stimulated ATPase pumps in parietal cells (IC50: 5.2 μM).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 626 | In Stock |
|
| 10MG | 889 | In Stock |
|
| 25MG | 1323 | In Stock |
|
| 50MG | 1782 | In Stock |
|
| 100MG | 2403 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameLevolansoprazole
-
NoteResearch use only, not for human use.
-
Brief DescriptionLevolansoprazole, a proton pump inhibitor, irreversibly inhibits H+/K+-stimulated ATPase pumps in parietal cells (IC50: 5.2 μM).
-
DescriptionLevolansoprazole, a proton pump inhibitor, irreversibly inhibits H+/K+-stimulated ATPase pumps in parietal cells (IC50: 5.2 μM). It also inhibits acid formation in isolated canine parietal cells (IC50: 82 μM). Both (R)- and (S)-lansoprazole are pharmacologically active with similar potencies.
-
In Vitro——
-
In Vivo——
-
Synonyms(S)-Lansoprazole | (-)-Lansoprazole
-
PathwayMembrane Transporter/Ion Channel
-
TargetProton Pump
-
Recptorproton pump
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number138530-95-7
-
Formula Weight369.36
-
Molecular FormulaC16H14F3N3O2S
-
Purity>98% (HPLC)
-
SolubilityDMSO:Soluble
-
SMILESCc1c(C[S@@](c([nH]2)nc3c2cccc3)=O)nccc1OCC(F)(F)F
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Gellad WF, Choi P, Mizah M, Good CB, Kesselheim AS. Assessing the chiral switch: approval and use of single-enantiomer drugs, 2001 to 2011. Am J Manag Care. 2014 Mar 1;20(3):e90-7. PubMed PMID: 24773330.
molnova catalog
related products
-
Pantoprazole sodium ...
A proton pump inhibitor that inhibits gastric acid secretion; works on gastric parietal cells to irreversibly inhibit (H+/K+)-ATPase function and suppress the production of gastric acid.
-
WY-47766
WY-47766 (OST-766) is a small molecule proton pump inhibitor that can be used to study postmenopausal osteoporosis.
-
Tegoprazan
A novel potent, highly selective, competitive and orally active inhibitor of gastric H+/K+-ATPase with IC50 of ranging 0.29-0.52 uM porcine, canine and human H+/K+-ATPases in vitro.
